Two executives at Bayoil Inc. have pled guilty to participating in the United Nations' alleged oil-for-food kickback scheme, only days before the founder of the Texas refinery is due to stand trial on similar charges related to the Iraqi government scandal.
In a blow to Walgreens Co., a Florida jury has ordered the pharmaceutical giant to shell out $25.8 million to the family of a deceased cancer patient who suffered a devastating stroke after one of the company's pharmacy technicians made a key prescription mistake.
The U.S. Patent and Trademark Office dealt Pfizer Inc. another blow Thursday in the company's ongoing fight to hang onto its patents to the world's best-selling drug, cholesterol treatment Lipitor, when it rejected the drugmaker's bid to extend one of the patents.
There was good and bad news for health care giant Ventana Medical Systems Inc. this week, as the company announced it had resolved a long-running patent dispute, but lost another.
The U.S. Securities and Exchange Commission and a U.S. Attorney's office have dropped stock options backdating investigations into CVS Caremark Corp., the company revealed Friday.
In the wake of a June ruling that AstraZeneca, Bristol-Myers Squibb and Schering-Plough Corp. inflated average wholesale prices of drugs, plaintiffs have asked the court to decide whether to grant treble damages and attorneys' fees before entering a final judgment.
C.B. Fleet Co. Inc.’s over-the-counter laxative used to prepare patients for colonoscopy procedures has been hit with a wave of lawsuits in at least 20 states for allegedly causing severe kidney complications and death.
Guidant Corp. has lashed out at a bid by a plaintiff who sued the medical device maker over its allegedly faulty implantable heart defibrillators to lift a stay in his case, arguing that the move would only frustrate the ongoing settlement process in the multidistrict litigation.
Biotechnology company Threshold Pharmaceuticals made a bid on Thursday to get a proposed securities class action filed against the company last month transferred to the Northern District of California.
Women who take the heart medication amiodarone to treat a type of abnormal heart rhythm may have a greater chance of needing a pacemaker later in life, a new study indicates.
A subsidiary of medical device maker Biomet has asked the U.S. Supreme Court to hear a long-running patent infringement suit against Medtronic Sofamor Danek Inc., after losing a high-stakes appeal earlier this year
An appellate court has upheld the conviction of the former president of Impath Inc., who federal prosecutors are still hoping to jail for life on alleged securities fraud charges that led to the cancer company's bankruptcy and liquidation.
Two additional cases have been transferred to the Human Tissue multidistrict litigation this week, joining almost 200 suits that allege patients became vulnerable to HIV and other infectious diseases after having the blood tissue of cadavers inserted during medical procedures.
In a move that could have far-reaching implications for attorney-client privilege in the digital age, the federal district judge overseeing the Vioxx multidistrict litigation has ordered Merck & Co. to begin handing over documents, taking a hard line on the nature of privileged documents in electronic discovery.
Just days after deciding not to pull GlaxoSmithKline PLC's Avandia Type 2 diabetes drug from the shelves, the U.S. Food and Drug Administration has instead gotten the company and other manufacturers of antidiabetic medications to update their labels to reflect the risks of heart failure.
The plaintiffs in a suit against Pfizer Inc. have sought class action certification from a federal judge in Manhattan, marking the latest development in a series of legal battles between pharmaceutical companies and workers who claim the companies improperly classified them as exempt from overtime pay.
Latham & Watkins LLP's product liability team is unfazed by unwieldy, complex tort cases. The reasons, its practice heads say: an adaptable attorney roster with a glut of scientific and regulatory expertise.
Knowing the law isn't enough for a successful product liability practice. For Morrison & Foerster, knowing products is an important competitive advantage, says Donald G. Rushing, the practice's co-chair.
Teva Pharamaceuticals USA Inc. has challenged a judge's decision blocking the generic drug maker from horning in on the market for the blockbuster blood-thinning drug Plavix, in a case in which Teva agreed to be bound by the same judge's ruling on a challenge to Sanofi's Plavix patent by Apotex in a separate case.
The judge in the consolidated Accutane product liability action dealt a major blow to the plaintiffs Wednesday when he blocked their move to hear experts' assessments of whether use of the acne drug caused suicide.